Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep278 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Response to direct antiviral agents in chronic hepatitis C in patients with metabolic syndrome

Soumaya Mrabet , raida harbi , Akkari Imen , Elhem Ben Jazia

IntroductionDirect antiviral agents (DAAs) are a real revolution in the treatment of chronic hepatitis c (CHC). It is a short-term treatment with few side effects. Insulin resistance in patients with metabolic syndrome, causes the onset of steatosis, contributes to the progression to cirrhosis and decreases the chances of a response to treatment. The aim of our study was to evaluate the response to DAAs in patients with metablic syndrome.<p class="ab...

ea0073aep328 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Non alcoholic steatohepatitis related cirrhosis and hepatocellulair carcinoma: A ten years rerospective study

Soumaya Mrabet , Raida Harbi , Akkari Imen , Elhem Ben Jazia

IntroductionCurrently, the incidence of metabolic steatopathies is clearly increasing. Unlike simple fatty liver disease, non-alcoholic steatohepatitis (NASH) can progress to cirrhosis and hepatocellular carcinoma (HCC). The aim of our study was to determine the factors associated with these complications in patients with NASH.MethodsThis is a retrospective study including all cirrhotic patients followed betw...

ea0073aep358 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Impact of diabetes on liver fibrosis in chronic hepatitis C

Soumaya Mrabet , Raida Harbi , Akkari Imen , Elhem Ben Jazia

IntroductionChronic hepatitis C (CHC) is associated with an increased incidence of insulin resistance and diabetes mellitus. Obesity and insulin resistance are associated with faster progression of fibrosis in these patients. The aim of our study was to assess the impact of diabetes on the severity of hepatic fibrosis in patients followed for CHC.MethodsThis is a retrospective study conducted between January ...

ea0073ep119 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Gluten free diet in real life

Akkari Imen , Raida Harbi , Soumaya Mrabet , Jazia Elhem Ben

IntroductionThe only currently available treatment of coeliac disease is a gluten-free diet (GFD). It improves outcomes, and reduces health-care costs. However, adhering to a gluten-free diet is difficult for many people. The aim of this study is to evaluate the diet adherence in real life and his impact on disease evolution.Patients and methodsThis is a descriptive transversal study carried out over a period...

ea0073ep137 | General Endocrinology | ECE2021

Extra-digestive manifestations of celiac disease

Akkari Imen , Raida Harbi , Soumaya Mrabet , Jazia Elhem Ben

IntroductionCeliac disease is an autoimmune enteropathy secondary to gluten intolerance developing in genetically predisposed patients. The atypical presentation is the most common form of the disease. The aim of this work is to report the various extradigestive manifestations associated with celiac disease.Patients and methodsThis is a descriptive transversal study carried out over a period of 10 years. All ...

ea0073ep140 | General Endocrinology | ECE2021

Thrombosis and coeliac disease

Akkari Imen , Raida Harbi , Soumaya Mrabet , Jazia Elhem Ben

IntroductionThe occurrence of thromboembolic events in celiac disease has been reported in the literature, especially in adults. The objective of our study is to determine the prevalence and clinical characteristics of thrombosis in celiac disease and to clarify the role of thrombophilic factors.Patients and methodsThis is a retrospective series of four observations of thrombosis among a cohort of 41 patients...